Quantitative analysis of [carbonyl-11C]WAY-100635 PET studies

被引:41
作者
Gunn, RN
Lammertsma, AA
Grasby, PM
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, MRC, Cyclotron Unit, London W12 0NN, England
[2] Free Univ Amsterdam Hosp, PET Ctr, Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
carbonyl-C-11]WAY-100635; 5-HT1A receptor; PET; modeling;
D O I
10.1016/S0969-8051(00)00115-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[carbonyl-C-11]WAY-100635 {[C-11]N-(2-(4-(2-methoxyphenyl)-1-piperazin-1-yl)ethyl)-N- (2-pyridyl)cyclohexanecarboxamide) is a positron-emission tomography (PET) radioligand for in vivo imaging of the 5-hydroxvtryptamine(1A) (5-HT1A) receptor. This paper assesses and summarises various different modeling strategies for the quantitative analysis of the radioligand. The models considered are based on a compartmental description of the ligands behaviour and include both plasma input analyses, requiring the additional monitoring of blood activity, and a reference tissue approach, which relies solely on the tomographic tissue data. Parameter estimates of specific binding are presented for a set of test-retest data, obtained from six normal volunteers who were scanned on two separate occasions, allowing for an assessment of normal binding values and their reproducibility, NUCL MED BIOL 27;5:477-482, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:477 / 482
页数:6
相关论文
共 35 条
[11]   Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET [J].
Gunn, RN ;
Sargent, PA ;
Bench, CJ ;
Rabiner, EA ;
Osman, S ;
Pike, VW ;
Hume, SP ;
Grasby, PM ;
Lammertsma, AA .
NEUROIMAGE, 1998, 8 (04) :426-440
[12]  
GUNN RN, 2000, PHYSL IMAGING BRAIN, P171
[13]   Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [H-3]WAY-100635 and [C-11]WAY-100635 [J].
Hall, H ;
Lundkvist, C ;
Halldin, C ;
Farde, L ;
Pike, VW ;
McCarron, JA ;
Fletcher, A ;
Cliffe, IA ;
Barf, T ;
Wikstrom, H ;
Sedvall, G .
BRAIN RESEARCH, 1997, 745 (1-2) :96-108
[14]  
Hirani E, 2000, SYNAPSE, V36, P330, DOI 10.1002/(SICI)1098-2396(20000615)36:4<330::AID-SYN10>3.0.CO
[15]  
2-H
[16]   EVALUATION OF [O-METHYL-H-3]WAY-100635 AS AN IN-VIVO RADIOLIGAND FOR 5-HT1A RECEPTORS IN RAT-BRAIN [J].
HUME, SP ;
ASHWORTH, S ;
OPACKAJUFFRY, J ;
AHIER, RG ;
LAMMERTSMA, AA ;
PIKE, VW ;
CLIFFE, IA ;
FLETCHER, A ;
WHITE, AC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (2-3) :515-523
[17]   Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals [J].
Hume, SP ;
Gunn, RN ;
Jones, T .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (02) :173-176
[18]   THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN - THEORY, PROCEDURE AND NORMAL VALUES [J].
KETY, SS ;
SCHMIDT, CF .
JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (04) :476-483
[19]  
KHAWAJA X, 1995, J NEUROCHEM, V64, P2716
[20]   Comparison of methods for analysis of clinical [C-11]raclopride studies [J].
Lammertsma, AA ;
Bench, CJ ;
Hume, SP ;
Osman, S ;
Gunn, K ;
Brooks, DJ ;
Frackowiak, RSJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (01) :42-52